ArticleThe Journal of clinical investigation2026

CXCR2 blockade overcomes the NETosis-mediated resistance to MEK inhibition in pancreatic cancer models.

Brian Herbst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.